GeneReach Biotechnology Corp. (TPEX:4171)

GeneReach Biotechnology Statistics

Total Valuation

TPEX:4171 has a market cap or net worth of TWD 1.24 billion. The enterprise value is 1.21 billion.

Market Cap	1.24B
Enterprise Value	1.21B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4171 has 57.70 million shares outstanding. The number of shares has decreased by -0.46% in one year.

Current Share Class	57.70M
Shares Outstanding	57.70M
Shares Change (YoY)	-0.46%
Shares Change (QoQ)	-0.82%
Owned by Insiders (%)	5.31%
Owned by Institutions (%)	0.13%
Float	42.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.76
PB Ratio	2.10
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.18
EV / Sales	5.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-32.20

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.37.

Current Ratio	2.39
Quick Ratio	1.46
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-5.88
Interest Coverage	-14.24

Financial Efficiency

Return on equity (ROE) is -22.47% and return on invested capital (ROIC) is -6.60%.

Return on Equity (ROE)	-22.47%
Return on Assets (ROA)	-6.19%
Return on Invested Capital (ROIC)	-6.60%
Return on Capital Employed (ROCE)	-14.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	1.90

Taxes

In the past 12 months, TPEX:4171 has paid 6.70 million in taxes.

Income Tax	6.70M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.82% in the last 52 weeks. The beta is 0.50, so TPEX:4171's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-21.82%
50-Day Moving Average	19.76
200-Day Moving Average	20.17
Relative Strength Index (RSI)	66.22
Average Volume (20 Days)	229,233

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4171 had revenue of TWD 215.32 million and -148.46 million in losses. Loss per share was -2.60.

Revenue	215.32M
Gross Profit	144.79M
Operating Income	-97.62M
Pretax Income	-145.29M
Net Income	-148.46M
EBITDA	-36.72M
EBIT	-97.62M
Loss Per Share	-2.60

Balance Sheet

The company has 257.35 million in cash and 221.70 million in debt, with a net cash position of 35.65 million or 0.62 per share.

Cash & Cash Equivalents	257.35M
Total Debt	221.70M
Net Cash	35.65M
Net Cash Per Share	0.62
Equity (Book Value)	591.73M
Book Value Per Share	10.08
Working Capital	272.16M

Cash Flow

In the last 12 months, operating cash flow was -31.28 million and capital expenditures -6.46 million, giving a free cash flow of -37.74 million.

Operating Cash Flow	-31.28M
Capital Expenditures	-6.46M
Free Cash Flow	-37.74M
FCF Per Share	-0.65

Margins

Gross margin is 67.25%, with operating and profit margins of -45.33% and -68.95%.

Gross Margin	67.25%
Operating Margin	-45.33%
Pretax Margin	-67.47%
Profit Margin	-68.95%
EBITDA Margin	-17.05%
EBIT Margin	-45.33%
FCF Margin	n/a

Dividends & Yields

TPEX:4171 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.46%
Shareholder Yield	0.46%
Earnings Yield	-11.97%
FCF Yield	-3.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.

Last Split Date	Jul 28, 2023
Split Type	Forward
Split Ratio	1.25

Scores

TPEX:4171 has an Altman Z-Score of 2.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	3